Congress Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Congress Asset Management's HALO Position: Q2 2026 in Review
Congress Asset Management reduced its Halozyme (HALO) stake by 4% in Q2 2026, selling an estimated $3.51M and leaving 1,229,106 shares worth $96.2M. The position accounts for 0.59% of the portfolio, ranked #63.
Congress Asset Management first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. The position peaked at $139M in Q3 2024. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Congress Asset Management held 1,229,106 shares of Halozyme worth $96.2M as of Q2 2026.
- Congress Asset Management sold 51,486 Halozyme shares in Q2 2026, an estimated $3.51M.
- Halozyme made up 0.59% of Congress Asset Management's portfolio in Q2 2026, its #63 holding.
- Congress Asset Management first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
- Congress Asset Management's Halozyme position peaked at $139M in Q3 2024.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.